Isabelle Boccon-Gibod Selected Research

Acquired angioedema

1/2021	Efficacy of lanadelumab in acquired angioedema with C1-inhibitor deficiency.
1/2020	Measurement of Bradykinin Formation and Degradation in Blood Plasma: Relevance for Acquired Angioedema Associated With Angiotensin Converting Enzyme Inhibition and for Hereditary Angioedema Due to Factor XII or Plasminogen Gene Variants.
1/2017	Idiopathic Non-histaminergic Angioedema: Successful Treatment with Omalizumab in Five Patients.
1/2014	Diagnosis and treatment of bradykinin-mediated angioedema: outcomes from an angioedema expert consensus meeting.
10/2012	Acquired C1-inhibitor deficiency: 7 patients treated with rituximab.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Isabelle Boccon-Gibod Research Topics

Disease

14	Angioedema 01/2021 - 11/2008
13	Hereditary Angioedemas 03/2022 - 11/2008
5	Acquired angioedema 01/2021 - 10/2012
3	Chronic Urticaria 02/2021 - 01/2017
2	Edema (Dropsy) 01/2020 - 06/2016
2	Rare Diseases (Rare Disease) 01/2017 - 07/2015
1	Substance Withdrawal Syndrome (Withdrawal Symptoms) 01/2022
1	Hepatitis E 07/2020
1	Wounds and Injuries (Trauma) 07/2020
1	Brachial Plexus Neuritis (Parsonage Turner Syndrome) 07/2020
1	Guillain-Barre Syndrome 07/2020
1	Cholestasis 07/2020
1	Hyperandrogenism 01/2020
1	Neoplasms (Cancer) 01/2020
1	Anaphylaxis (Anaphylactic Shock) 01/2018
1	Adenocarcinoma 08/2016
1	Lymphoma (Lymphomas) 08/2016
1	Immunoglobulin Light-chain Amyloidosis 08/2016
1	Abdominal Pain (Pain, Abdominal) 01/2016
1	Urticaria (Hives) 01/2016
1	Paraproteinemias (Monoclonal Gammopathy) 10/2012
1	Hereditary Angioedema Type III 11/2009

Drug/Important Bio-Agent (IBA)

9	BradykininIBA 01/2020 - 01/2014
3	Omalizumab (Xolair)FDA Link 02/2021 - 01/2017
3	icatibantIBA 01/2017 - 11/2009
3	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 06/2016 - 01/2014
2	lanadelumabIBA 01/2021 - 01/2021
2	Estrogens (Estrogen)FDA Link 01/2021 - 01/2020
2	PlasminogenIBA 01/2020 - 11/2018
2	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2020 - 01/2019
2	Pharmaceutical PreparationsIBA 01/2019 - 01/2016
2	Histamine Antagonists (Antihistamines)IBA 01/2017 - 01/2014
2	Rituximab (Mabthera)FDA Link 08/2016 - 10/2012
1	AndrogensIBA 01/2022
1	Complement C1 (Complement 1)IBA 08/2021
1	RNA (Ribonucleic Acid)IBA 07/2020
1	Immunoglobulin M (IgM)IBA 07/2020
1	Transaminases (Aminotransferases)IBA 07/2020
1	Hormones (Hormone)IBA 01/2020
1	Factor XII (Hageman Factor)IBA 01/2020
1	Epinephrine (Adrenaline)FDA LinkGeneric 01/2018
1	Immunoglobulin E (IgE)IBA 10/2017
1	Amyloid (Amyloid Fibrils)IBA 08/2016
1	Immunoglobulins (Immunoglobulin)IBA 08/2016
1	Angiotensin Receptor AntagonistsIBA 01/2016
1	Biomarkers (Surrogate Marker)IBA 01/2016
1	Biological ProductsIBA 05/2014
1	GlucocorticoidsIBA 01/2014
1	AutoantibodiesIBA 10/2012
1	Bradykinin Receptors (Bradykinin Receptor)IBA 11/2009
1	Gonadal Steroid Hormones (Sex Hormones)IBA 11/2008

Therapy/Procedure

2	Therapeutics 03/2022 - 01/2022
1	Contraception (Birth Control) 01/2020
1	Drug Therapy (Chemotherapy) 08/2016
1	Splenectomy 08/2016